A Republican-led House panel has advanced a 2024 budget bill that includes riders to revoke key Food and Drug Administration (FDA) approvals regarding where patients are allowed to access abortion drug mifepristone, in a quiet move aimed at limiting abortion access nationwide. The legislation passed the House Agriculture, Rural Development, Food and Drug Administration Appropriations Subcommittee…
BROADCASTING FOR INDEPENDENCE
